Keywords
Last Name
Institution

James N. Fleming

Title
InstitutionMedical University of South Carolina
DepartmentCOP Clinical Pharmacy and Outcome Sciences - MUSC Campus
Address
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Fleming JN, Zhang J, Taber DJ, McCauley JL, Schumann S, Mauldin PD, Ball S. The effect of targeted insurer-mandated prescription monitoring on opioid prescribing patterns. J Am Pharm Assoc (2003). 2020 Feb 04. PMID: 32033899.
      View in: PubMed
    2. Fleming JN, Posadas Salas MA, Taber DJ. Dosing Requirements of Extended-Release Tacrolimus (Astagraf XL) in African American Kidney Transplant Recipients Converted from Immediate Release Tacrolimus (AAAKTRS). Ther Drug Monit. 2019 Dec 23. PMID: 31913864.
      View in: PubMed
    3. Taber DJ, Pilch NA, McGillicuddy JW, Mardis C, Treiber F, Fleming JN. Using informatics and mobile health to improve medication safety monitoring in kidney transplant recipients. Am J Health Syst Pharm. 2019 Jul 18; 76(15):1143-1149. PMID: 31361870.
      View in: PubMed
    4. Taber DJ, Su Z, Fleming JN, Pilch NA, Morinelli T, Mauldin P, Dubay D. The impact of time-varying clinical surrogates on disparities in African-American kidney transplant recipients - a retrospective longitudinal cohort study. Transpl Int. 2019 01; 32(1):84-94. PMID: 30176087.
      View in: PubMed
    5. Pilch NA, Fleming JN, Crowther BR, Maldonado AQ, Taber DJ. It is time for board certification in transplant pharmacotherapy. Am J Transplant. 2018 09; 18(9):2370-2371. PMID: 29856528.
      View in: PubMed
    6. Fleming JN, Treiber F, McGillicuddy J, Gebregziabher M, Taber DJ. Improving Transplant Medication Safety Through a Pharmacist-Empowered, Patient-Centered, mHealth-Based Intervention: TRANSAFE Rx Study Protocol. JMIR Res Protoc. 2018 Mar 02; 7(3):e59. PMID: 29500161.
      View in: PubMed
    7. Fleming JN, Taber DJ, Pilch NA, Mardis CR, Gilbert RE, Wilson LZ, Patel N, Ball S, Mauldin P, Baliga PK. Association of Pretransplantion Opioid Use with Graft Loss or Death in Liver Transplantation Patients with Model of End-Stage Liver Disease Exceptions. J Am Coll Surg. 2018 04; 226(4):651-659. PMID: 29309943.
      View in: PubMed
    8. Fleming JN, Taber DJ, Weimert NA, Nadig S, McGillicuddy JW, Bratton CF, Baliga PK, Chavin KD. Valganciclovir (VGCV) followed by cytomegalovirus (CMV) hyperimmune globulin compared to VGCV for 200 days in abdominal organ transplant recipients at high risk for CMV infection: A prospective, randomized pilot study. Transpl Infect Dis. 2017 Dec; 19(6). PMID: 28921781.
      View in: PubMed
    9. Taber DJ, Su Z, Fleming JN, McGillicuddy JW, Posadas-Salas MA, Treiber FA, Dubay D, Srinivas TR, Mauldin PD, Moran WP, Baliga PK. Tacrolimus Trough Concentration Variability and Disparities in African American Kidney Transplantation. Transplantation. 2017 12; 101(12):2931-2938. PMID: 28658199.
      View in: PubMed
    10. Fleming JN, Lai JC, Te HS, Said A, Spengler EK, Rogal SS. Opioid and opioid substitution therapy in liver transplant candidates: A survey of center policies and practices. Clin Transplant. 2017 Dec; 31(12). PMID: 28941292.
      View in: PubMed
    11. Spengler EK, O'Leary JG, Te HS, Rogal S, Pillai AA, Al-Osaimi A, Desai A, Fleming JN, Ganger D, Seetharam A, Tsoulfas G, Montenovo M, Lai JC. Liver Transplantation in the Obese Cirrhotic Patient. Transplantation. 2017 10; 101(10):2288-2296. PMID: 28930104.
      View in: PubMed
    12. Veasey TM, Fleming JN, Strout SE, Miller R, Pilch NA, Meadows HB, Mardis CR, Mardis BA, Shenvi S, McGillicuddy J, Chavin KD, Baliga P, Taber DJ. Morbid obesity and functional status as predictors of surgical complication after renal transplantation. Am J Surg. 2018 Apr; 215(4):663-668. PMID: 28622834.
      View in: PubMed
    13. Casale JP, Taber DJ, Staino C, Boyle K, Covert K, Pilch NA, Mardis C, Meadows HB, Chavin KD, McGillicuddy JW, Baliga PK, Fleming JN. Effectiveness of an Evidence-Based Induction Therapy Protocol Revision in Adult Kidney Transplant Recipients. Pharmacotherapy. 2017 Jun; 37(6):692-699. PMID: 28475248.
      View in: PubMed
    14. Covert KL, Mardis CR, Fleming JN, Pilch NA, Meadows HB, Mardis BA, Mohan P, Posadas-Salas M, Srinivas T, Taber DJ. Development of a Predictive Model for Drug-Related Problems in Kidney Transplant Recipients. Pharmacotherapy. 2017 02; 37(2):159-169. PMID: 27997676.
      View in: PubMed
    15. Taber DJ, Fleming JN, Fominaya CE, Gebregziabher M, Hunt KJ, Srinivas TR, Baliga PK, McGillicuddy JW, Egede LE. The Impact of Health Care Appointment Non-Adherence on Graft Outcomes in Kidney Transplantation. Am J Nephrol. 2017; 45(1):91-98. PMID: 27907919.
      View in: PubMed
    16. Fleming JN, Taber DJ, Pilch NA, Srinivas TR, Chavin KD. Yes, We Still Need IL-2 Receptor Antagonists. Am J Transplant. 2016 11; 16(11):3308-3309. PMID: 27321737.
      View in: PubMed
    17. Covert KL, Fleming JN, Staino C, Casale JP, Boyle KM, Pilch NA, Meadows HB, Mardis CR, McGillicuddy JW, Nadig S, Bratton CF, Chavin KD, Baliga PK, Taber DJ. Predicting and preventing readmissions in kidney transplant recipients. Clin Transplant. 2016 07; 30(7):779-86. PMID: 27101090.
      View in: PubMed
    18. Fleming JN, Taber DJ, Pilch NA, McGillicuddy JW, Srinivas TR, Baliga PK, Chavin KD, Bratton CF. A randomized, prospective comparison of transition to sirolimus-based CNI-minimization or withdrawal in African American kidney transplant recipients. Clin Transplant. 2016 05; 30(5):528-33. PMID: 26914542.
      View in: PubMed
    19. Morbitzer KA, Taber DJ, Pilch NA, Meadows HB, Fleming JN, Bratton CF, McGillicuddy JW, Baliga PK, Chavin KD. The impact of diabetes mellitus and glycemic control on clinical outcomes following liver transplant for hepatitis C. Clin Transplant. 2014 Aug; 28(8):862-8. PMID: 24893750.
      View in: PubMed
    20. Taber DJ, Spivey JR, Tsurutis VM, Pilch NA, Meadows HB, Fleming JN, McGillicuddy JW, Bratton CF, Treiber FA, Baliga PK, Chavin KD. Clinical and economic outcomes associated with medication errors in kidney transplantation. Clin J Am Soc Nephrol. 2014 May; 9(5):960-6. PMID: 24763866.
      View in: PubMed
    21. Rech MA, Fleming JN, Moore CL. 25-hydroxyvitamin D deficiency and opportunistic viral infections after kidney transplant. Exp Clin Transplant. 2014 Apr; 12(2):95-100. PMID: 24702139.
      View in: PubMed
    22. Taber DJ, Srinivas TM, Pilch NA, Meadows HB, Fleming JN, McGillicuddy JW, Bratton CF, Thomas B, Chavin KD, Baliga PK, Egede LE. Are thiazide diuretics safe and effective antihypertensive therapy in kidney transplant recipients? Am J Nephrol. 2013; 38(4):285-91. PMID: 24061145.
      View in: PubMed
    23. Fleming JN, Malinzak L, Abouljoud M. Effect of standardized medication-order forms on medication errors after liver or kidney transplantation. Am J Health Syst Pharm. 2012 Jun 01; 69(11):916-7. PMID: 22610018.
      View in: PubMed
    24. Fleming JN, Abou Abbass A. Hepatorenal syndrome: a comprehensive overview for the critical care nurse. Crit Care Nurs Clin North Am. 2010 Sep; 22(3):351-68. PMID: 20691386.
      View in: PubMed
    25. Fleming JN, Weimert NA. Novel strategies for immune monitoring in kidney transplant recipients. Adv Chronic Kidney Dis. 2010 Sep; 17(5):e63-77. PMID: 20727505.
      View in: PubMed
    26. Fleming JN, Taber DJ, Weimert NA, Egidi MF, McGillicuddy J, Bratton CF, Lin A, Chavin KD, Baliga PK. Comparison of efficacy of induction therapy in low immunologic risk African-American kidney transplant recipients. Transpl Int. 2010 May 01; 23(5):500-5. PMID: 19951304.
      View in: PubMed
    Fleming's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description